QPARIKQ

Serial Number 98812807
730

Registration Progress

Application Filed
Oct 21, 2024
Under Examination
Mar 25, 2025
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Mar 25, 2026 140 days

Trademark Image

QPARIKQ

Basic Information

Serial Number
98812807
Filing Date
October 21, 2024
Published for Opposition
January 28, 2025
Drawing Code
5

Status Summary

Current Status
Active
Status Code
730
Status Date
Sep 10, 2025
Application
Pending
Classes
005 016 044

Rights Holder

Incyte Holdings Corporation

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

Incyte Holdings Corporation

Original Applicant
03
Wilmington, DE

Incyte Holdings Corporation

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
140 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
March 25, 2026
Extension Available
Until March 25, 2026

Application History

12 events
Date Code Type Description Documents
Sep 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 10, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 10, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 21, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders

Additional Information

Design Mark
The mark consists of the word "QPARIK" followed by a stylized "Q".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 016 044